With the cannabis industry rising in the global market, plethora of companies are emerging with the intent of making it big in the health care domain along with significant revenue generations.
Supreme Cannabis, a marijuana company recently signed a letter of intent (LOI) with Malta Enterprises, the economic development agency of Malta. A letter of intent is the first step to obtain a cannabis production license in Malta, a strategically located place to serve export markets throughout Europe.
Malta is strategically located in Europe with surfeit options for cannabis trade. An array of pharmaceutical and nutraceutical manufacturing industries nestles in Malta which provides gateways for medicinal research and usage of cannabis for the general populace in an efficient manner.
The LOI would allow the Supreme Cannabis Company to produce and process cannabis for medicinal use within Malta and even export it to certain international markets. If approved, the Supreme Cannabis intends to create products containing EU GMP cannabis oil and practice continual medicinal production and distribution throughout the European Union.
“We’re pleased to announce that we have secured a letter of intent from Malta Enterprises, taking another step forward in our global growth strategy. Malta is not only a strategic hub for Europe, it is also home to robust existing pharmaceutical and nutraceutical manufacturing industries with a deep pool of expertise.” said Navdeep Dhaliwal, CEO of The Supreme Cannabis Company. He further added, “Using the intellectual property and expertise we’ve gained in Canada, we intend to deliver high-quality cannabis products to medical patients in multiple international markets.”
Everything About Supreme Cannabis
The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is a Canadian publicly traded company which is committed to proffer premium brands and products that its consumers like and which in turn promotes an uniquely creative culture.
Supreme Cannabis incorporates 7 ACRES, a wholly owned subsidiary and a multi-award-winning brand. It is a federally licensed cannabis producer operating inside a 440,000 square-foot facility in Kincardine, Ontario.
7 ACRES has acquired an eminent position in the cannabis industry owing to its multiple award wins including the “Brand of the Year” award at the 2018 Canadian Cannabis Awards. It also ranks consistently in the highest brand category available to recreational consumers in terms of provincial supply agreements with 7 ACRES products.
The Supreme Cannabis Company has seen tremendous growth since its inception.It has been a pioneering innovator in the sector including the design of growing facilities and development of operational excellence metrics.
The flagship brand along with its proprietary technology and products envisions a consistent long-term value creation with its clientele and consumers.Supreme Cannabis’s ultimate goal is heavy equity investments and long-term global distribution partnerships with Lesotho-based Medigrow for exporting medical-grade cannabis oil.
Exponential growth can be observed from the manufacturing process to the distribution of cannabis products as stock markets are predicted to incline heavily towards cannabis stocks. Investors are constantly on the look out for profitable companies that stand strong in the cannabis industry with a promising future.
The Supreme Cannabis Company seems to be an eminent player in the global cannabis industry with a letter of intent issued for legal production of cannabis in Malta, Europe. It not only plans to expand its services but also focus remarkably on distributing quality-driven products to its consumers.